---
title: "百本醫護控股有限公司 (02293.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/02293.HK.md"
symbol: "02293.HK"
name: "百本醫護控股有限公司"
industry: "醫療服務"
---

# 百本醫護控股有限公司 (02293.HK)

| Item | Detail |
|------|--------|
| Industry | 醫療服務 |
| Location | 港股市場 |
| Website | [www.bamboos.com.hk](https://www.bamboos.com.hk) |

## Company Profile

百本醫護控股有限公司提供“科技+創新”賦能的一站式醫療健康及智慧居家服務解決方案。集團自2009年創立以來,始終秉持“關懷備至”、“專業實幹”、“全心全意”的服務理念,近年在堅守核心業務的同時,推進「科技+創新」與醫療健康的融合,持續優化服務質素和效率、加深業務合作及拓展業務內容,整合預防醫學、中西醫療、智慧養老及適老化生活解決方案叁大服務板塊,構建了全新的“百本健康”生態。集團亦積極利用旺角自購實體空間,現已構建了一個集醫療保健及智慧居家人工智能養老科技和數據的服務平臺——“healtHUB”。集團目前已從最初的提供醫護人手解決方案發展成為覆蓋“預防-治療-康復-居家照護-智慧養老”全生命周...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-17T04:30:09.000Z

**Overall: C (0.54)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 15 / 29 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -21.52% |  |
| Net Profit YoY | -43.27% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.86 |  |
| Dividend Ratio | 8.16% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 197.17M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 74.95M |  |


**Multi Score**: C

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 7.84% | B |
| Profit Margin | 23.40% | A |
| Gross Margin | 54.45% | B |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -21.52% | E |
| Net Profit YoY | -43.27% | D |
| Total Assets YoY | -0.68% | D |
| Net Assets YoY | 5.06% | B |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 427.39% | C |
| OCF YoY | -21.52% | E |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.24 | D |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 27.39% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 百本醫護控股有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "7.84%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "23.40%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "54.45%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-21.52%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-43.27%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-0.68%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "5.06%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "427.39%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-21.52%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.24",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "27.39%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 固生堂 (HK.2273) | B | B | B | B | B | B |
| 02 | 盈健醫療 (HK.1419) | C | C | B | B | B | B |
| 03 | 環球醫療 (HK.2666) | B | C | D | D | B | C |
| 04 | 健康之路 (HK.2587) | B | C | A | D | E | C |
| 05 | 卓正醫療 (HK.2677) | D | A | B | E | B | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 11.24 | 6/30 | 11.47 | 9.77 | 9.09 |
| PB | 0.86 | 12/30 | 1.02 | 0.97 | 0.89 |
| PS (TTM) | 2.65 | 24/30 | 2.87 | 2.67 | 2.60 |
| Dividend Yield | 8.16% | 1/30 | 9.62% | 9.09% | 8.25% |

## References

- [Company Overview](https://longbridge.com/en/quote/02293.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/02293.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/02293.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.